Nova Patents
ATE548386T1

Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 5 January 2026, 0.7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

86 members in 23 offices

This recordMember, by publication datePriority claim13 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
64114405United States of AmericaP

Members86

Family members, oldest first
DocumentOfficeKind
AU2006204459A1AustraliaA1
CA2594356A1CanadaA1
WO2006072620A1World Intellectual Property Organization (WIPO)A1
EP1699826A1European Patent Office (EPO)A1
EP1752471A1European Patent Office (EPO)A1
EP1772465A1European Patent Office (EPO)A1
KR20070092242ARepublic of KoreaA
IL184103A0IsraelA0
IL184103D0IsraelD0
CN101098891AChinaA
EA200701443A1Eurasian Patent Organization (EAPO)A1
MX2007008118AMexicoA
JP2008526809AJapanA
EP1752471B1European Patent Office (EPO)B1
AT414718TAustriaT
ATE414718T1AustriaT1
DE602006003695D1GermanyD1
EP1772465B1European Patent Office (EPO)B1
EP2028193A1European Patent Office (EPO)A1
PT1752471EPortugalE
EP1699826B1European Patent Office (EPO)B1
AT423140TAustriaT
AT425186TAustriaT
ATE423140T1AustriaT1
ATE425186T1AustriaT1
DK1752471T3DenmarkT3
HRP20090087T3CroatiaT3
DE602006005200D1GermanyD1
EP1752471B9European Patent Office (EPO)B9
DE602006005526D1GermanyD1
PL1752471T3PolandT3
SI1752471T1SloveniaT1
ES2320374T3SpainT3
PT1772465EPortugalE
DK1772465T3DenmarkT3
HRP20090228T1CroatiaT1
ES2321861T3SpainT3
PT1699826EPortugalE
BRPI0606399A2BrazilA2
SI1772465T1SloveniaT1
DK1699826T3DenmarkT3
ES2323651T3SpainT3
HRP20090326T1CroatiaT1
PL1699826T3PolandT3
PL1772465T3PolandT3
SI1699826T1SloveniaT1
US2009298195A1United States of AmericaA1
NZ555893ANew ZealandA
RS50752BSerbiaB
RS50785BSerbiaB
RS50830BSerbiaB
IL184103AIsraelA
US2011251375A1United States of AmericaA1
US2012028303A1United States of AmericaA1
US2012028839A1United States of AmericaA1
EP2028193B1European Patent Office (EPO)B1
AT548386TAustriaT
ATE548386T1This recordAustriaT1
JP4937138B2JapanB2
PT2028193EPortugalE
ES2384039T3SpainT3
DK2028193T3DenmarkT3
JP2012131792AJapanA
AU2006204459B2AustraliaB2
KR20130105885ARepublic of KoreaA
EA018897B1Eurasian Patent Organization (EAPO)B1
CN103555733AChinaA
JP2014058564AJapanA
CY1108767T1CyprusT1
JP5483294B2JapanB2
CN101098891BChinaB
CY1109143T1CyprusT1
KR101404512B1Republic of KoreaB1
JP5717833B2JapanB2
US9045528B2United States of AmericaB2
CY1110895T1CyprusT1
US2017204164A1United States of AmericaA1
US9856311B2United States of AmericaB2
CA2594356CCanadaC
US10385118B2United States of AmericaB2
US2019382470A1United States of AmericaA1
US2020079837A1United States of AmericaA1
US11084868B2United States of AmericaB2
US11499249B2United States of AmericaB2
BRPI0606399A8BrazilA8
US2023340696A1United States of AmericaA1